is the most potent member of a class of chlorinated hydrocarbons that interact with the aryl hydrocarbon receptor (AhR). TCDD and dioxinlike compounds are environmentally and biologically stable and as a result, human exposure is chronic and widespread. Studies of highly exposed human populations show that dioxins produce developmental effects, chloracne, and an increase in all cancers and suggest that they may also alter immune and endocrine function. In contrast, the health effects of low-level environmental exposure have not been established. Experimental animal models can enhance the understanding of the effects of low-level dioxin exposure, particularly when there is evidence that humans respond similarly to the animal models. Although there are species differences in pharmacokinetics, experimental animal models demonstrate AhR-dependent health effects that are similar to those found in exposed human populations. Comparisons of biochemical changes show that humans and animal models have similar degrees of sensitivity to dioxin-induced effects. The information gained from animal models is important for developing mechanistic models of dioxin toxicity and critical for assessing the risks to human populations under different circumstances of exposure.
Introduction
Dioxins are a class of highly toxic and broadly dispersed environmental contaminants that may pose a significant risk to human health. Dioxins include 75 polychlorinated dibenzodioxins (PCDDs), 135 polychlorinated dibenzofurans (PCDFs), and nine coplanar and mono-ortho-substituted polychlorinated biphenyls (PCBs) that are structurally similar to PCDDs and PCDFs (1, 2) . The most potent member of this family is 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD), which also has the greatest affinity for the aryl hydrocarbon receptor (AhR). For simplicity, the term dioxin will be used to refer to any of these compounds that act as AhR ligands and elicit dioxinlike effects.
Dioxins are the unintentional contaminants of many processes involving organic materials and chlorine. Combustion, incineration, synthesis of phenoxy herbicides and wood preservatives, and industrial and municipal processes such as paper manufacturing are the principal sources of dioxins (3) . Most dioxins are resistant to environmental and biologic degradation This paper is based on a presentation at the International Symposium on Dioxins and Furans: Epidemiologic and once formed, disperse throughout the atmosphere, soil, and water (3) . Although environmental concentrations of dioxins are generally low, they bioaccumulate in human foodstuffs because of their lipophilicity and stability.
Human exposures are lifelong and universal and usually consist of a mixture of dioxins. Approximately 80% of human environmental exposure to dioxins comes from the consumption of fat-containing foods such as milk, meat, and fish (4, 5) . Although dioxins can be detected in water, soil, and dust, these sources contribute relatively little to human exposure (6) .
Total exposure to mixtures of dioxins can be assessed by calculating the total toxic equivalent (TEQ). A toxic equivalency factor (TEF) is assigned to each dioxin based on its potency compared to TCDD. The TEQ is the sum of magnitude of exposure for each constituent dioxin multiplied by its respective TEF (7, 8) . The use of the TEQ is appropriate for PCDDs and PCDFs where TCDD alone or a mixture with an equivalent TEQ produce similar biologic effects (9) .
Humans metabolize dioxins slowly, as evidenced by the estimated TCDD halflife of 5.8 to 14.1 years (10, 11) . Many PCDFs have somewhat shorter half-lives of 2 to 4 years (12), whereas 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) has an estimated half-life of 19 .7 years in humans (13) (14) .
Because all humans contain dioxins in their bodies, background exposures may result in disease even if the incidence is low. It is expected that humans will differ in their susceptibility to the health effects produced by dioxins. Factors such as gender, developmental stage, and the effect of Phase I and II enzyme polymorphisms are likely to contribute to the variation in susceptibility. Therefore, investigative approaches that promote a better under-populations, and improve the science base for quantitative risk assessment. Integration of all available information describing the toxicokinetics, biochemistry, and health effects of dioxins in both human studies and animal models can be used to develop mechanistic models for risk assessment (15, 16) . The conceptual framework for considering human and animal data forms a parallelogram (Figure 1 ). This approach can be used to infer human responses by comparing human and animal in vitro data with animal in vivo effects. The relationship between responses in surrogate and target tissue can be similarly inferred through the use of an animal model. A 4 and 0.4%, respectively (GW Lucier, unpublished observations).°TEQ based on PCDDs and PCDFs. fExtrapolated to last known exposure based on serum TCDD concentration, first order elimination kinetics, and elimination half-lives measured in Flesch-Janys et al. (13) . #Calculated using the liver concentration of TCDD and assuming a liver:adipose ratio of 1 (27) . Acute toxicity has not been observed among highly exposed humans despite the occurrence of high accidental exposures that exceed the doses known to produce acute toxicity in guinea pigs (28) . The elicitation of the acute toxicity syndrome in rhesus macaques by PeCDF (29) suggests that whereas humans are tolerant, similar effects would be possible with sufficient exposure.
Chloracne is a reversible but often disfiguring skin condition characterized by acneiform eruptions due to epidermal hyperkeratosis and hyperplasia (30) . High exposures, where plasma levels exceed 100 ppt lipid, may produce chloracne in many, but not all, individuals (31, 32) . Individuals who consumed up to 1 g of PCDFs and PCBs in contaminated rice oil developed chloracne and dermatologic and metabolic disorders that are collectively referred to as Yu-cheng (33) . Animal species known to develop chloracnelike lesions include rhesus macaques, rabbits, and rodents (17, 27, 29) . In experimental animal models such as the rhesus macaque, the chloracnelike lesions may be accompanied by epidermal changes affecting the toenails and sebaceous glands (29) . Similar changes have been observed in human children exposed prenatally to high concentrations of PCDFs and PCBs (34) .
Reproductive, Developmental, and Immunologic Eff&ts Exposure to dioxins has been linked to alterations in endocrine and possibly reproductive capabilities in humans. In a population of highly exposed chemical plant workers, plasma levels of luteinizing hormone and follicle stimulating hormone were positively correlated to blood lipid dioxins that ranged from below 20 to 3400 ppt. There was also a trend for reduced testosterone in these workers (35) .
Few studies have examined reproductive outcome as a function of dioxin exposure in human populations. Indirect evidence that alterations in endocrine status may affect reproduction comes from a study of the gender ratio of children born to parents exposed by the accidental release of TCDD in Seveso. During the 7 years following the release, the proportion of female children was significantly elevated (48 females compared to 26 males) (36) .
In male rats, exposure to TCDD produces testicular abnormalities and reduces plasma testosterone levels (37) . Developmental exposure to TCDD in the male rat results in subsequent impairment of reproductive capabilities (38) .
Early exposure to toxicants can produce developmental effects in the form of physical malformations and altered growth and maturation. Some developmental effects, such as physical malformations, may be detectable at birth whereas others, such as changes in growth, can be manifested at any time until the onset of sexual maturity (39) .
The children of Taiwanese women with Yu-cheng were exposed to high concentrations of PCBs and PCDFs transplacentally and in some instances through breast milk. At ages 6 to 7 they exhibited disordered behavior, increased activity (40), and impaired cognitive development (41) .
A Dutch study examined the effect of the dioxins in normal breast milk by comparing breast-fed and formula-fed infants (42) . Standardized tests of mental and psychomotor development suggested a transitory reduction in psychomotor skills in the breast-fed infants that was related to their intake of contaminants. Even so, as a group, breast-fed infants performed better than formula-fed infants (42) . The children were also exposed to nondioxinlike PCBs, which other investigators have found to be related to reductions in psychomotor function (43) . The effect of the nondioxinlike PCBs was correlated with transplacental rather than perinatal exposure (43) .
Dioxins in breast milk may also alter the level of thyroid hormones in human infants. Highly exposed infants had elevated thyroid stimulating hormone (TSH) levels and lower free thyroxine (T4) levels than less-exposed infants. In all cases hormone levels were within normal clinical ranges (44) .
Experimental animal models support the putative developmental effects seen in humans. Exposure to dioxins adversely affected learning in young rhesus macaques (45) , whereas toxic levels of the dioxin PeCDF reduced the level of circulating T4 and increased TSH levels in adult rhesus macaques (29) . A similar pattern of altered plasma thyroid hormone was produced by TCDD in rats (46) . Exposure of rodents to dioxins either in utero or neonatally via maternal milk reduced body weight, delayed development, and caused immunologic disturbances (47, 48) . Dioxins are potent murine teratogens that produce hydronephrosis and cleft palates at doses below those producing maternal toxicity (23, 49 Studies of early human development suggest that low-level environmental exposure may also produce changes in the immune system. Prenatal exposure in human infants was estimated from maternal and infant plasma concentrations of planar, mono-, and di-ortho-substituted PCBs and PCDDs/PCDFs. Higher levels of exposure corresponded with fewer circulating T lymphocyte receptor subpopulations, monocytes, and granulocytes at birth and at 3 months. Prenatal exposure was also positively correlated with increased numbers of cytotoxic T cells at 18 months of age (58) . Immune function in children aged 6 to 10 years exposed during the Seveso accident showed no clinical evidence of immune abnormalities based on serum immunoglobulin concentrations and responses to T-and B-cell mitogens (59) . Subsequent to the TCDD release, 20 of the 44 children developed chloracne, which demonstrates that as a group their exposure to TCDD was considerable (59) .
In murine models, dioxins suppress antibody responses and to a lesser extent T lymphocyte responses. Low-dose exposure to dioxins decreased the frequency of memory T helper lymphocytes and suppressed both T-dependent and T-independent antibody responses (60, 61) . Dioxins may also affect nonspecific immunity by augmenting inflammatory responses (62) . Rodent studies show that dioxins impair immune function and, as a consequence, resistance to viral and parasitic infections is reduced (63, 64) . Dioxins produce involution of the thymus at doses that exceed those required to alter immune function (62 (28) , were used for a series of epidemiologic studies that examined cancer mortality and morbidity in the years following the release (65) (66) (67) . The outcomes observed in the Seveso population are particularly informative because in contrast to the occupational cohorts, substantial numbers of females and children were exposed.
Up to 15 years after the release, neither the incidence of cancer mortality nor morbidity in the zone with the highest level of contamination was elevated (65) (66) (67) . This seemingly contradictory finding is not surprising because the expected numbers of many rare cancers are less than one in the subpopulation of approximately 800 individuals (67 A meta-analysis of selected cohorts showed excess mortality from cancers for all sites combined, lung cancer, and nonHodgkin's lymphoma, and weak evidence for an elevation in soft-tissue sarcoma and gastrointestinal cancers. (6) . The association of TCDD with an increase in all cancers was further strengthened by the dose dependence of the risk (13, 68) . In addition a nested case-control study showed that the odds ratio for non-Hodgkin's lymphoma and soft-tissue sarcoma was dependent on the magnitude of the estimated exposure (69) .
Animal models support the carcinogenic activity of TCDD based on studies of Syrian golden hamsters, rats, and mice (70) . Cancers observed in human populations, such as non-Hodgkin's lymphoma, gastrointestinal cancers, and soft-tissue sarcomas, are not replicated in the animal models. However, comparison of the experimental animal models shows that specific cancers may be species, strain, or gender specific. In both Sprague-Dawley and Osborne-Mendel rats, female but not male rats develop liver cancer (71, 72) (80, 83) . Studies in animal models and human and animal cell systems that evaluate the structure-activity relationships for the various dioxins have shown a positive correlation between AhR binding affinity and the induction of aryl hydrocarbon hydroxylase (CYPlAI) activity, lethality, thymic atrophy, weight loss, and immunotoxicity (27, 80) .
The AhR is expressed in all tissues and species examined thus far (80, 84, 87) . Although an endogenous ligand for the AhR has not been identified, the high degree of conservation of functional domains across taxonomic lines suggests that the AhR is necessary for important cellular processes, particularly during development (83) . Evidence from transgenic mice lacking a functional AhR also supports this hypothesis (88, 89) .
The use of the resistant DBA/2J and the sensitive C57BL/6J mouse strains have shown that sensitivity of response to dioxins segregates with the AhR locus and is due to receptor structure rather than quantity (90 (81, 82, 97) . Only limited evidence currently exists for this mechanism in the dioxin-regulated expression of other genes, but is assumed to occur by a similar mechanism.
Treatment of human and murine lymphoid tissue in vitro with TCDD allows for the comparison of possible species-specific dose-response characteristics. Recent evidence from this laboratory showed that the dioxin responsiveness of human and murine lymphocytes were qualitatively and quantitatively similar. Human lymphocytes cultured with mitogen and TCDD showed increased CYPlAI (EROD) activity at concentrations as low as 0.5 nM in cell culture medium (74) (107) . This may be accounted for by an absence of functional significance for the genetic polymorphisms. Indeed, the Ile/Val polymorphism within the CYPlA1 catalytic domain was recently shown to have no effect on catalytic activity (109, 110) . Ethnic differences in allele frequencies may also account for the conflicting results. The CYPlAI Msp I variant allele associated in some studies with high enzyme inducibility has the greatest prevalence in Asian populations (111) . In a recent meta-analysis of several published studies, there was a significant link between the two CYPlAI genetic polymorphisms and cancer risk in Japanese populations but not Caucasians or other ethnic groups (111) .
Although an association between known CYPlAI genetic polymorphisms and inducibility has been noted in some studies (107) , it is unlikely these polymorphisms account for the observed range of CYPlAI inducibility phenotypes in the human population. Indeed, recent genetic evidence has shown the CYPlAI high inducibility phenotype segregates with the chromosomal region containing the AhR structural gene (112) . In the context of our current studies in dioxin-exposed populations, we are evaluating CYPlAI levels as possible biomarkers of exposure and susceptibility and attempting to identify factors that may explain and/or modify the interindividual variation in dioxin responsiveness. Preliminary evidence suggests that the distribution of CYPlA1 inducibility in human populations may be associated with the magnitude and/or pattern of exposure. A 7-fold range of inducibility was obtained in lymphocytes from 15 individuals with presumed background dioxin exposures. Lymphocytes from 85 occupationally exposed individuals showed a 27-fold variation in inducibility (104) , whereas those exposed in the Seveso accident showed an 11-fold variation (113) . Further analyses that correlate individual CYPlAl activity with exposure status will determine the degree to which these differences correspond to either dioxin exposure or responsiveness.
Although it is possible to measure CYPlAl induction after in vivo dioxin exposure in human tissues such as lymphocytes, the analysis of CYPlAl expression in animal models has been critical in characterizing the dose response for effects of TCDD exposure on gene expression in vivo. CYPlAl is inducible by TCDD and other AhR agonists in multiple animal models and in tissues, including liver, lung, kidney, and small intestine (114) (115) (116) . In the rat liver, immunohistochemical analysis of the dose-dependent expression of CYPlAI protein in chronically exposed animals shows that the number of cells expressing CYPlAI increases with increasing dose in a centrilobular-specific pattern (73) . Even at high doses some cells are not induced, which suggests that individual cells may differ in their TCDD dose-response characteristics (73) . CYPlAI expression has been observed in human liver and also exhibits a similar pattern of expression (117), although it is not known whether this pattern is related to dioxin exposures. Induction of CYP 1Al expression in the rat liver is the most sensitive response observed in vivo following exposure to TCDD (118) . Significant increases in CYPlAI expression have been observed at liver TCDD concentrations as low as 64 ppt lipid (assuming a lipid concentration of 4%), a level that is elevated but within the range of dioxin concentrations observed in human livers (6) .
While CYPIAI induction in vivo is highly correlated with dioxin exposure in animal models and indicative of a functional AhR signal transduction pathway, the role of CYPlAI in the development of adverse heath affects associated with dioxin exposure is unknown.
Cytochrome P450 1A2
CYP1A2 is the second member of the TCDD-inducible CYPIA subfamily and, Environmental Health Perspectives * Vol 106, Supplement 2 * April 1998 like CYPlA1, is induced by TCDD via an AhR-dependent pathway and a mechanism similar to that of CYPlAl. In contrast to CYPlAl, CYP1A2 expression is observed in normal livers and inducibility by AhR agonists is primarily localized to the liver (114) , although expression has been detected in other tissues.
CYP1A2 expression has been observed in the liver of humans with presumed background environmental exposure to dioxins (119) . The levels of CYP1A2 mRNA in the liver of these individuals varies about 20-fold and is from 2 to 30 times higher than the expression of CYPlAl molecules (119) . Whether the variability in CYPlAl and CYP1A2 levels is related to dioxin exposure is not known.
CYP1A2 activity can be detected in humans indirectly by monitoring metabolites in urine (120) or exhaled air (121) after the administration of caffeine. CYP1A2 expression is induced in humans by ingestion of omeprazole, smoking blonde tobacco (120) , and eating pan-fried meats (122) . Elevated CYP1A2 activities have also been observed in chemical plant workers who had serum levels as high as 147 ppt of TCDD (123) , although these findings were not statistically significant.
In rats chronically exposed to TCDD, CYP1A2 protein is induced in the liver approximately 10-fold, compared to 200-fold for CYPlAl, yet the maximum level of expression of the two CYPIA isozymes is similar (73, 124) . Like CYPlAl, the induction of CYP1A2 with increasing liver TCDD burden exhibits a centrilobular-specific pattern of expression (73) . CYP 1A2 expression is an important factor in comparative pharmacokinetics of TCDD between species because it functions as a TCDD binding protein (125) , and as a result is responsible for hepatic sequestration of TCDD in rodents (126) .
In contrast to CYPlAl, the expression of CYP1A2 is implicated in one mechanism of hepatocarcinogenesis of TCDD in rats. CYP1A2 is involved in the metabolism of estrogen to catechol estrogens (127) , which may serve as a source for reactive oxygen species and may potentially result in oxidative stress and indirect genotoxicity (128) . CYP1A2 also catalyzes the N-oxidation of arylamines (129) and has been linked to an increase in risk for colorectal cancer (130) .
Cytocom e P450 1B1 Cytochrome P450 iB1 (CYP1Bi) is the first member of a TCDD-inducible CYPIB subfamily of cytochromes P450 that has been cloned from humans (131, 132) , mice (133, 134) , and rats (135, 136) . Human and rodent CYP1B1 proteins catalyze the bioactivation of a broad spectrum of compounds including polycyclic aromatic hydrocarbons and aromatic amines (137) (138) (139) . Truncating mutations in human CYP1B1 are the primary cause of congenital glaucoma in humans (140) , which suggests that CYPIBI is involved in the metabolism of endogenous substrates involved in normal cell growth and differentiation. Human CYPiBi is active in the formation of the catechol estrogen 4-hydroxyestradiol (141), which is carcinogenic in male hamsters (142) . The formation of 4-hydroxyestradiol has been implicated in the development of human mammary tumors and uterine leiomyoma (143) , and CYPiBi protein expression is frequently observed in wide variety of malignant tumors (144) . CYP1Bi therefore represents a TCDD-inducible gene that is plausibly linked in multiple mechanisms of carcinogenesis through the formation of potentially genotoxic metabolites of estrogens, the activation of procarcinogens, and altered cell growth and differentiation.
CYP1Bi is normally expressed in human fetal heart, brain, and kidney (138) and in rat adrenal glands and testes (135, 136) . Expression of CYP1 B I is inducible by TCDD in multiple human cell lines (131, 132, 145) and in multiple rodent tissues, including liver, lung, and kidney (135) . CYPIBI also exhibits a centrilobular pattern of expression in TCDD-treated rat liver (146) but is expressed at lower levels and exhibits a TCDD dose response different from that of CYPlAI (147, 148) .
CYPIBI expression is detectable in human lymphocytes and inducible by TCDD in mitogen-stimulated lymphocytes treated with TCDD in vitro (104 
Epidermal Grwth Factor Receptor
The epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein with tyrosine kinase activity that mediates the actions of the polypeptide hormones epidermal growth factor (EGF) and transforming growth factor alpha. Ligand binding results in receptor autophosphorylation and internalization accompanied by phosphorylation and activation of downstream effector proteins (150) . The EGFR is widely expressed and functions in cellular growth and differentiation in multiple tissues including the liver and gastrointestinal tract (151) . The EGFR also regulates the implantation, growth, and differentiation of the placenta (152) , and alterations in EGFR signaling pathways may be involved in carcinogenesis (153) .
EGF-stimulated autophosphorylation of the EGFR in placentas from women with Yu-cheng was reduced by approximately 60% compared to unexposed controls (76) . The reduction in autophosphorylation of the EGFR was highly correlated with the reduction in birth weight seen in the offspring of the exposed mothers, and with placental PCB, but not PCDF, concentration. TCDD treatment also reduces EGFR binding capacity in human keratinocytes (154) .
TCDD-mediated decreases in EGFR binding capacity were observed in both mice (155) and rats (156) . In the rat tumor promotion model, TCDD treatment led to a dose-dependent reduction in EGFR-stimulated autophosphorylation, EGFR protein, and EGFR maximal binding capacity while the ligand-binding affinity of the receptor was unaffected (156, 157) . The magnitude of the decrease (60%) was similar to that seen in placentas from women with Yu-cheng. In the rat model the reduction in EGFR binding was correlated with increased hepatocyte labeling index (156) , suggesting a possible relationship to tumor promotion. Both the decrease in EGFR levels and the increased proliferation depend on the presence of ovarian hormones because the TCDDmediated changes were greater in intact than ovariectomized female rats (156) .
Despite a similar maximal magnitude of reduction in EGFR autophosphorylation in the rat model and women with Yucheng, EGFR (70) . One putative mechanism for thyroid carcinogenesis is that decreased concentrations of serum thyroid hormones leads to a negative feedback regulation on the hypothalamic and pituitary glands, which results in an increase in secretion of TSH. Prolonged stimulation of the thyroid gland by TSH may lead to follicular cell hyperplasia and subsequently to tumors (158) . UDP-GT is a Phase II conjugating enzyme that glucuronidates thyroid hormones and is active in the excretion of a variety of other endogenous and exogenous molecules (159) . UDP-GT is inducible by TCDD in human and rat tissues (160, 161) , and several animal studies have shown that TCDD as well as other compounds that increase hepatic levels of UDP-GT lower circulating levels of thyroid hormones, presumably through a UDP-GT-mediated increase in clearance from the body (162, 163) . Evidence also exists that dioxin exposure is associated with altered thyroid hormone status in human populations (44, 164, 165) .
Dioxin-related changes in the serum levels of T4, 3,5,3'-triiodothyronine (T3), TSH, and UDP-GT mRNA were measured in a rat tumor promotion model (166) . TCDD treatment led to a dosedependent decrease in serum T4, which correlated with liver TCDD burden and increased UDP-GT mRNA. These changes were accompanied by increased serum TSH and thyroid follicular cell hyperplasia. Significant changes in these end points occurred at liver burdens of 450 to 1800 ppt TCDD wet weight, equivalent to a daily dose of 3.5 to 10.7 ng/kg/day for 30 weeks.
The mechanisms and dosimetry underlying these observed biologic phenomena were further examined by physiological modeling of the alterations in thyroid hormones and induction of UDP-GT observed in the rat (167) . The thyroid hormones T3 and T4 were added to an existing mechanistic model of TCDD (168) by adding compartments and terms for secretion, uptake, transport, glucuronidation, and deiodination. The model incorporates the induction of UDP-GT by TCDD via the AhR complex and the subsequent increase in glucuronidation of T4. T4 secretion was modeled as regulated by hypothalamic and pituitary factors, which in turn were based on a feedback mechanism controlled by blood levels of T4. The resultant model successfully reproduced blood T3, T4, and TSH levels in rats receiving biweekly oral dosing. The ability of this model to accurately represent biologic processes is demonstrated by the correct prediction of liver TCDD concentrations and UDP-GT expression. Data measuring these end points were not used to construct the model, but were confirmed experimentally (167) .
Cellular Proliferaion and Differentiation
Although a direct causal relationship between changes in cellular growth and differentiation and adverse health effects is not known, disruption of cellular homeostasis could certainly be a risk factor for carcinogenicity or other toxic effects.
Changes in cellular proliferation and differentiation represent critical steps in dioxin carcinogenicity that cannot readily be studied in exposed human populations. Chronic exposure to TCDD in animal models results in a broad spectrum of changes in cell proliferation and differentiation (169, 170) . This likely results from the effect of dioxins on multiple hormone and growth factor signal transduction pathways that are involved in cell growth and homeostasis. The development of altered hepatic foci, characterized by the expression of the enzymes y-glutamyltranspeptidase and placental glutathione S-transferase (124, 171) , is the result of a complex interaction between cell proliferation, apoptosis, and hepatocyte differentiation. In a rat two-stage tumor promotion model, chronic exposure to increasing doses of TCDD up to 125 ng/kg/day for 30 weeks results in increased cell proliferation and altered hepatic foci formation (172, 173) . Both the number and size of the foci are increased by dioxin exposure (172) , although there is considerable interindividual variability in response that does not correlate with either liver TCDD concentration or with the induction of cytochrome P450s (172) . TCDD-induced increases in cell proliferation and foci development are dependent on the presence of ovarian hormones (124) , and this correlates with the female-specific induction of tumors in rats (71) . One of the characteristics of tumor promotion is reversibility on cessation of treatment. Withdrawal of TCDD treatment leads to a reduction in number of altered hepatic foci; however, the focal size and percent of liver occupied by foci increases (173) (174) (175) . These data suggest that TCDD treatment may promote the development of a population of foci that may be able to continue to develop in the absence of TCDD.
Although the response to dioxins has been best characterized in liver tissue, animal models show that dioxin alters proliferation and differentiation in other tissues as well. In mice, prenatal TCDD exposure results in cleft palate due to a disruption in proliferation and differentiation of epithelial cells required for fusion of the palatal shelves (176 (178) .
In vitro systems allow for the study of the effects of TCDD on growth and proliferation of human cells including primary and immortalized keratinocytes, embryonic craniofacial tissues, and MCF-7 breast cancer cell line. Normal human epidermal keratinocytes treated with 10 nM TCDD showed an increase in markers of terminal differentiation while the total number of cells remained constant (179) . The estrogen-dependent growth of MCF-7 cells was inhibited by 0.3 nM TCDD (180) . In addition, several studies have shown that TCDD can induce transformation of both rodent and human cells in vitro (170) .
Gender Differences in Response
Evidence from the analysis of serum TCDD levels in the Seveso population suggests that dioxin pharmacokinetics may differ in respect to gender. Twenty years after the initial exposure, the average serum level in females was approximately three times that found in males (181 Rodent cancer bioassays indicate that TCDD is a hepatic carcinogen in female but not male rats (71) , implying that the presence of estrogens influences the carcinogenic response. Indications that a similar process occurs in humans comes from the 10-year follow-up of those exposed in the Seveso incident. Women but not men showed an excess of liver cancer (66) . This excess was present but not statistically significant 15 years after the accident (67) .
Rodent models suggest that the presence of ovarian hormones, presumably estrogens, play a role in modifying many effects of TCDD that are correlated either with the development of hepatic preneoplastic changes or tumors. Compared to ovariectomized rats, the livers of intact animals treated with TCDD for 30 weeks showed a decrease in EGF receptor (156) , a greater hepatic proliferative response (73, 124) , a greater volume occupied by putative preneoplastic lesions (124) , and increased oxidative DNA damage (182) , while the quantity of CYP1A2 was not affected (124) .
Summary
The adverse effects of dioxins are well established based on studies of experimental animal models and highly exposed human populations. From these investigations, the current view of dioxins as potent toxicants capable of producing a multitude of diverse biologic effects has emerged.
Much less is known about the risk posed to humans by lifelong low-level environmental exposure. Better characterization of dose-response relationships and the factors associated with individual variation in susceptibility are needed to evaluate the risk to humans from background exposures. These questions can best be addressed with experimental animal models, provided the response of the animal species accurately replicates the human response. The relevance of a particular animal model for evaluating or predicting human response is determined by a number of properties-factors that can Based on reviews of exposed humans, the corresponding experimental animal models, and the biochemical responses in human and animals, biologic responses to dioxins are qualitatively and often quantitatively similar. Exposure to dioxins has been implicated in a wide range of human health effects related to reproduction, immune function, growth and development, and cancer. The role of dioxins in producing these effects is supported by corresponding outcomes in animal models. The similarity in biochemical responses makes it possible to study the underlying mechanisms of dioxin toxicity relevant for humans. Most important, animal models make it possible to study the relationship between simple biochemical responses and more complex responses, such as altered growth and differentiation, which lead to adverse health effects. This information is integrated with human studies to infer responses that would not otherwise be possible, such as target tissue effects. Current efforts are underway to characterize the effect of susceptibility factors such as genetics, gender, age, and the dosimetry of dioxin-dependent biochemical changes in human populations. Parallel studies in animal models can be used to understand how these biochemical changes can lead to adverse health effects.
